Literature DB >> 2458295

Vascular effects of calcium antagonists. Uses in some cerebrovascular disorders.

J Marin1.   

Abstract

1. Smooth muscle contraction is related to the intracellular free Ca2+ concentration. 2. Potential dependent Ca2+ channels (PDCs) are generally more sensitive to Ca2+-antagonists (CAts) than receptor-operated Ca2+ channels (ROCs). However, there exists a wide variation in the sensitivity of ROCs and CAts, which largely depends on the vessel studied. 3. Cerebral and coronary arteries seem to be very sensitive to CAts. 4. New dihydropyridines possess selectivity for the cerebrovascular bed. 5. The vasospasm subsequent to subarachnoid hemorrhage appears to be sensitive to CAts. 6. CAts prevent or reduce the neurologic alterations elicited by cerebral ischemia, and some of them induce beneficial effects in the prophylaxis of migraine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458295     DOI: 10.1016/0306-3623(88)90020-1

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  4 in total

1.  Synergistic internal carotid vasodilator effects of human alpha-calcitonin gene-related peptide and nimodipine in conscious rats.

Authors:  S M Gardiner; A M Compton; T Bennett; P A Kemp; U Ney
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

2.  Pre-operative micro-angioplasty of refractory vasospasm secondary to subarachnoid hemorrhage.

Authors:  J E Dion; G R Duckwiler; F Viñuela; N Martin; J Bentson
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

3.  Effects of 5-hydroxytryptamine on human isolated placental chorionic arteries and veins.

Authors:  J Reviriego; J Marín
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

4.  Functional role of sodium pump in human placental arteries.

Authors:  M S Fernández-Alfonso; C F Sánchez-Ferrer; M Salaices; J Marín
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.